MicroPort CardioFlow Medtech Corp. (HK:2160) has released an update.
MicroPort CardioFlow Medtech Corp. has announced a significant transaction, involving the acquisition of the entire equity interest of an unnamed target company from Shanghai MicroPort Medical. This acquisition is classified as both a disclosable and connected transaction according to Listing Rules, requiring approval from independent shareholders. The deal is based on the net asset value of the target company, with a fixed property value mentioned in a recent valuation report.
For further insights into HK:2160 stock, check out TipRanks’ Stock Analysis page.
